<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fetuin inhibits insulin-induced insulin receptor (IR) autophosphorylation and tyrosine kinase activity in vitro, in intact cells, and in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>The fetuin gene (AHSG) is located on human chromosome 3q27, recently identified as a susceptibility locus for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we explore insulin signaling, <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis, and the effect of a high-fat diet on <z:mp ids='MP_0005456'>weight gain</z:mp>, body fat composition, and <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal in mice carrying two null alleles for the gene encoding fetuin, Ahsg (B6, 129-Ahsg(tm1Mbl)) </plain></SENT>
<SENT sid="3" pm="."><plain>Fetuin knockout (KO) mice demonstrate increased basal and insulin-stimulated phosphorylation of IR and the downstream signaling molecules <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase (MAPK) and Akt in liver and skeletal muscle </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> and insulin tolerance tests in fetuin KO mice indicate significantly enhanced <z:chebi fb="105" ids="17234">glucose</z:chebi> clearance and insulin sensitivity </plain></SENT>
<SENT sid="5" pm="."><plain>Fetuin KO mice subjected to euglycemic-hyperinsulinemic clamp show augmented sensitivity to insulin, evidenced by increased <z:chebi fb="105" ids="17234">glucose</z:chebi> infusion rate (P = 0.077) and significantly increased skeletal muscle <z:chebi fb="15" ids="28087">glycogen</z:chebi> content (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>When fed a high-fat diet, fetuin KO mice are resistant to <z:mp ids='MP_0005456'>weight gain</z:mp>, demonstrate significantly decreased body fat, and remain insulin sensitive </plain></SENT>
<SENT sid="7" pm="."><plain>These data suggest that fetuin may play a significant role in regulating postprandial <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal, insulin sensitivity, <z:mp ids='MP_0005456'>weight gain</z:mp>, and fat accumulation and may be a novel therapeutic target in the treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0001513'>obesity</z:hpo>, and other insulin-resistant conditions </plain></SENT>
</text></document>